当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析 - 现金流量表

誉衡药业

(002437)

  

流通市值:78.64亿  总市值:84.07亿
流通股本:20.86亿   总股本:22.30亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金564,644,445.272,371,185,934.251,847,160,364.271,211,784,742.07
  收到的税费返还247,117.07546,693.48546,693.48546,693.48
  收到其他与经营活动有关的现金19,877,053.78108,219,340.2888,834,654.0448,963,812.56
  经营活动现金流入小计584,768,616.122,479,951,968.011,936,541,711.791,261,295,248.11
  购买商品、接受劳务支付的现金102,849,275.27423,728,767.03278,548,454.92168,639,415.73
  支付给职工以及为职工支付的现金77,458,703.98317,706,963.64250,117,152.68173,650,677.2
  支付的各项税费50,895,460.69241,013,926.27170,860,855.27114,206,256.66
  支付其他与经营活动有关的现金280,854,886.91,224,146,797.6928,750,388.51649,584,119.99
  经营活动现金流出小计512,058,326.842,206,596,454.541,628,276,851.381,106,080,469.58
  经营活动产生的现金流量净额72,710,289.28273,355,513.47308,264,860.41155,214,778.53
二、投资活动产生的现金流量:
  收回投资收到的现金425,167,3801,268,858,383.65933,499,000692,999,000
  取得投资收益收到的现金3,266,043.6741,481,560.1434,110,196.664,270,757.25
  处置固定资产、无形资产和其他长期资产收回的现金净额19,198,00011,420,946.4411,405,365.9111,066,705.91
  投资活动现金流入小计447,631,423.671,321,760,890.23979,014,562.57708,336,463.16
  购建固定资产、无形资产和其他长期资产支付的现金4,282,920.3123,814,355.9817,581,670.9813,318,605.54
  投资支付的现金175,000,0001,630,000,0001,290,000,0001,010,000,000
  取得子公司及其他营业单位支付的现金-299,343257,556-
  投资活动现金流出小计179,282,920.311,654,113,698.981,307,839,226.981,023,318,605.54
  投资活动产生的现金流量净额268,348,503.36-332,352,808.75-328,824,664.41-314,982,142.38
三、筹资活动产生的现金流量:
  取得借款收到的现金-90,000,00070,000,00070,000,000
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-90,000,00070,000,00070,000,000
  偿还债务支付的现金70,000,000---
  分配股利、利润或偿付利息支付的现金340,333.346,830,966.096,387,591.096,038,757.76
  其中:子公司支付给少数股东的股利、利润-5,621,674.435,621,674.435,621,674.43
  支付其他与筹资活动有关的现金3,203,009.72107,219,468.2983,872,599.0682,687,095.5
  筹资活动现金流出小计73,543,343.06114,050,434.3890,260,190.1588,725,853.26
  筹资活动产生的现金流量净额-73,543,343.06-24,050,434.38-20,260,190.15-18,725,853.26
四、汇率变动对现金及现金等价物的影响-1,436,780.01-1,887,808.59-968,043.41-266,848.95
五、现金及现金等价物净增加额266,078,669.57-84,935,538.25-41,788,037.56-178,760,066.06
  加:期初现金及现金等价物余额395,828,907.76480,772,690.45480,772,690.45480,772,690.45
  期末现金及现金等价物余额661,907,577.33395,837,152.2438,984,652.89302,012,624.39
补充资料:
  净利润-382,357,127.75-137,424,012.98
  资产减值准备-10,253,095.65-910,744.9
  固定资产和投资性房地产折旧-55,603,103.24-27,841,117.61
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-55,603,103.24-27,841,117.61
  无形资产摊销-33,832,277.04-16,813,986.98
  处置固定资产、无形资产和其他长期资产的损失--3,542,703.45--3,660,243.29
  固定资产报废损失-610,504.12-62,680.86
  公允价值变动损失--5,977,821.1--8,559,844.12
  财务费用-4,225,254.36-824,015.84
  投资损失--136,525,191.03--175,170.34
  递延所得税--160,360.82-1,019,439.73
  其中:递延所得税资产减少--70,640.68-1,281,690.78
    递延所得税负债增加--89,720.14--262,251.05
  存货的减少--19,218,202.55-18,331,603.98
  经营性应收项目的减少--6,626,051.17-9,397,371.65
  经营性应付项目的增加--50,331,385.5--52,777,434.73
  其他-7,498,162.21-7,083,644.12
  现金的期末余额-395,837,152.2-302,012,624.39
  减:现金的期初余额-480,772,690.45-480,772,690.45
  现金及现金等价物的净增加额--84,935,538.25--178,760,066.06
公告日期2026-04-282026-04-282025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑